DMDavid M. Menge

David M. Menge

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


David M. Menge has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Andrew Githeko

    Center for Vector Biology and Control Research, Kenya Medical Research Institute, Kisumu, Kenya

    1 shared publication
  • Chandy C. John

    Center for Infectious Diseases and Microbiology Translational Research, University of Minnesota, Minneapolis, Minnesota; University of Michigan School of Public Health, Ann Arbor, Michigan; Climate and Human Health Research Unit, Centre for Vector Biology and Control Research, Kenya Medical Research Institute, Kisumu, Kenya; Office of Clinical Research, Division of Biostatistics, University of Minnesota, Minneapolis, MN; The Center for Global Health and Diseases...

    1 shared publication
  • Daibin Zhong

    Program in Public Health, College of Health Sciences, University of California at Irvine, Irvine, USA

    1 shared publication
  • Guiyun Yan

    Joe C. Wen School of Population & Public Health, University of California at Irvine , Irvine, CA

    1 shared publication
  • Hongfei Guo

    Center for Infectious Diseases and Microbiology Translational Research, University of Minnesota, Minneapolis, Minnesota; University of Michigan School of Public Health, Ann Arbor, Michigan; Climate and Human Health Research Unit, Centre for Vector Biology and Control Research, Kenya Medical Research Institute, Kisumu, Kenya; Office of Clinical Research, Division of Biostatistics, University of Minnesota, Minneapolis, MN; The Center for Global Health and Diseases...

    1 shared publication
  • John M. Vulule

    Center for Infectious Diseases and Microbiology Translational Research, University of Minnesota, Minneapolis, Minnesota; University of Michigan School of Public Health, Ann Arbor, Michigan; Climate and Human Health Research Unit, Centre for Vector Biology and Control Research, Kenya Medical Research Institute, Kisumu, Kenya; Office of Clinical Research, Division of Biostatistics, University of Minnesota, Minneapolis, MN; The Center for Global Health and Diseases...

    1 shared publication

Latest Publications

  • Microscopy Underestimates the Frequency of Plasmodium Falciparum Infection in Symptomatic Individuals in a Low Transmission Highland Area

    by David M. Menge, Kacey C. Ernst, John M. Vulule, Peter A. Zimmerman, Hongfei Guo, Chandy C. John

    In an area with unstable malaria transmission, detection of Plasmodium falciparum infection in 379 symptomatic individuals was assessed by microscopy and three polymerase chain reaction (PCR) methodologies. P. falciparum infection was detected in 25% of patients by microscopy, 37% by nested PCR, 41% by merozoite surface protein-2 (MSP-2) PCR, and 45% by a ligase detection reaction-fluorescent microsphere assay (LDR-FMA). Of the 64 individuals who were LDR-FMA positive, microscopy negative and did not receive treatment, 8 (12.5%) had persistent symptoms and returned for treatment. Malaria attributable fraction (MAF) in symptomatic individuals was 14.6% by microscopy (95% confidence interval [CI] = 6.6–21.8%) and 28.2% by nested PCR (95% CI = 17.9–37.2%). In this highland area, P. falciparum infection in symptomatic individuals is detected more frequently by PCR than microscopy, and most frequently by LDR-FMA. P. falciparum infection appears to resolve without treatment in most LDR-FMA-positive, microscopy-negative individuals, but is persistent in a subset of these individuals and requires treatment.


  • Open Access

    Molecular epidemiology of drug-resistant malaria in western Kenya highlands

    by Daibin Zhong, Yaw Afrane, Andrew Githeko, Liwang Cui, David M Menge, Guiyun Yan

    Since the late 1980s a series of malaria epidemics has occurred in western Kenya highlands. Among the possible factors that may contribute to the highland malaria epidemics, parasite resistance to antimalarials has not been well investigated. Using parasites from highland and lowland areas of western Kenya, we examined key mutations associated with Plasmodium falciparum resistance to sulfadoxine – pyrimethamine and chloroquine, including dihydrofolate reductase (pfdhfr) and dihydropteroate synthetase (pfdhps), chloroquine resistance transporter gene (pfcrt), and multi-drug resistance gene 1 (pfmdr1). We found that >70% of samples harbored 76T pfcrt mutations and over 80% of samples harbored quintuple mutations (51I/59R/108N pfdhfr and 437G/540E pfdhps) in both highland and lowland samples. Further, we did not detect significant difference in the frequencies of these mutations between symptomatic and asymptomatic malaria volunteers, and between highland and lowland samples. These findings suggest that drug resistance of malaria parasites in the highlands could be contributed by the mutations and their high frequencies as found in the lowland. The results are discussed in terms of the role of drug resistance as a driving force for malaria outbreaks in the highlands.